Molecular Pharmaceutics
[ASAP] Impact of Crystal Nuclei on Dissolution of Amorphous Drugs
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00989
Molecular Pharmaceutics
[ASAP] Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: <italic toggle=”yes”>Ex Vivo</italic> and <italic toggle=”yes”>In Vivo</italic> Evaluations
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00943
Molecular Pharmaceutics
[ASAP] Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00962
Molecular Pharmaceutics
[ASAP] Implications of Drug–Polymer Interactions on Time–Temperature–Transformation: A Tool to Assess the Crystallization Propensity in Amorphous Solid Dispersions
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01004
Molecular Pharmaceutics
[ASAP] Synthesis and Evaluation of [<sup>11</sup>C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00915
Molecular Pharmaceutics
[ASAP] Influence of Co-amorphization on the Physical Stability and Dissolution Performance of an Anthelmintic Drug Flubendazole
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00873
Molecular Pharmaceutics
[ASAP] Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00895
Molecular Pharmaceutics
[ASAP] Voices in <italic toggle=”yes”>Molecular Pharmaceutics</italic>: Meet Darnell Cuylear, Who Combines Dentistry and Science to Design Calcium Phosphate Delivery Systems for Enhanced Tooth Stability
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00070
Molecular Pharmaceutics
[ASAP] Targeting Intratibial Osteosarcoma Using Water-Soluble Copolymers Conjugated to Collagen Hybridizing Peptides
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00880
Molecular Pharmaceutics
[ASAP] Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00970